Nanotechnology-based antiviral therapeutics
Nanotechnology has emerged as one of the most promising technologies on account of its ability to deal with viral diseases
A forum for researchers, students and applicants in the field of cyclodextrin technology
Nanotechnology has emerged as one of the most promising technologies on account of its ability to deal with viral diseases
Transdermal drug delivery offers advantages over nonparenteral routes such as bypassing first-pass metabolism and facile administration. Mammalian skin, however, functions
Making a comparison between CDs and the unique Ring of the legendary novel of The Lord of the Rings, J.
This article reviews the controlled release of current anticancer drugs based on cyclodextrins as a “flexible switch”, and discusses the
Cyclodextrin polymers have high applicability in pharmaceutical formulations due to better biocompatibility, solubility enhancement, loading capacity and controlled drug release
The European Commission has signed a contract with the pharmaceutical company Gilead to secure treatment doses of Veklury, the brand
Oculis, the Icelandic-Swiss clinical stage boipharmaceutical company recently announced that they are progressing towards Phase 3 with OCS-01 in two
There are two possible mechanisms behind the ototoxicity of 2-hydroxypropyl-β-cyclodextrin (HPBCD) treatment. One is : the possible interaction of HPBCD
Cyclodextrin‐soluble angiotensin‐converting enzyme 2 (CD‐sACE2) inclusion compounds can be useful in the treatment of SARS‐CoV‐2 infections by blocking S‐proteins .
Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents provides sound data on the utility of